Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Damien Luque Paz; Jean-Christophe Ianotto; Aurélie Chauveau; Briac Guibourg; Lydie Lecucq; Eric Lippert; Valérie Ugo

doi:10.1007/s00277-015-2518-5

Journal articles

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Damien Luque Paz ¹ Jean-Christophe Ianotto ^{2, 3} Aurélie Chauveau ^{4, 1} Briac Guibourg ⁵ Lydie Lecucq ¹ Eric Lippert ^{1, 4} Valérie Ugo ^{6, *}

* Corresponding author

1 Labo Hémato - BREST - Laboratoire d'hématologie

2 Institut de cancérologie et d'hématologie

3 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

4 GGB - Génétique, génomique fonctionnelle et biotechnologies (UMR 1078)

5 CHU - AnaPath - CHRU Brest - Laboratoire d'Anatomo-Pathologie

6 Laboratoire d'hématologie

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Human health and pathology

Life Sciences [q-bio] / Cancer

Complete list of metadata

https://hal.univ-brest.fr/hal-01282825
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Friday, March 4, 2016 - 1:36:43 PM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Identifiers

Collections

Citation

Export

Metrics

49

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Identifiers

Collections

Citation

Export

Share

Metrics

49